For citations:
Alekseev I.B., Samoilenko A.I., Belkin V.E., Abramova O.I., Soshina M.M., Aylarova А.K. Bimatoprost 0,03% efficacy and safety as a first-choice drug in patients with primary open-angle glaucoma. National Journal glaucoma. 2019;18(1):39-44. (In Russ.) https://doi.org/10.25700/NJG.2019.01.06
Email this article 